Biotech News

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

T2 Biosystems (TTOO)T2 BiosystemsEarnings

Achieved record fourth quarter and full-year 2024 sepsis product revenues LEXINGTON, Mass. , Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced

Related news

MDXHMDxHealth2026-10-15 20:00 EST

MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

DGXQuest Diagnostics2026-10-22 10:46 EST

Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

DGXQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

LUCDLucid Diagnostics2026-11-12 13:00 EST

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-11-09 21:05 EST

OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion

BRLIBio-Reference Laboratories2026-11-04 21:23 EST

OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results

OSUROraSure Technologies, Inc.2026-10-26 20:05 EST

OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th

SERASera Prognostics2026-10-21 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026

SERASera Prognostics2026-07-29 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026

BRLIBio-Reference Laboratories2026-07-27 20:05 EST

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

T2 Biosystems

T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.

Recent company news

Stock data

Close
0.00 USD
Market cap
—
Exchange
NASDAQ
Sector
MedTech
Location
United States